Aurobindo Pharma Ltd.

BSE: 524804 | NSE: AUROPHARMA |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE406A01037 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Aurobindo Phar Aurobindo Pharma Ltd. | BSE 1210.85 -1.80 (-0.15%) | NSE 1212.20 0.80 (0.07%) | Trade | Add

BSE Live

Dec 26, 10:51

1210.85 -1.80 (-0.15%)

Volume

AVERAGE VOLUME

5-Day

59,527

10-Day

33,844

30-Day

24,682

3,177

Prev. Close

1212.65
Open Price

1206.20

Bid Price (Qty.)
1211.10 (4)
Offer Price (Qty.)
1212.30 (6)

NSE Live

Dec 26, 10:51

1212.20 0.80 (0.07%)

Volume

AVERAGE VOLUME

5-Day

747,902

10-Day

657,341

30-Day

858,366

45,136

Prev. Close

1211.40
Open Price

1213.70

Bid Price (Qty.)
1211.80 (5)
Offer Price (Qty.)
1212.30 (53)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Aurobindo Pharma (in Rs. Cr.)	Mar 15	Mar 14	Mar 13	Mar 12	Mar 11
Per Share Ratios
Basic EPS (Rs.)	54.05	40.27	10.09	-4.24	19.57
Diluted EPS (Rs.)	54.00	40.22	10.09	-4.24	17.61
Cash EPS (Rs.)	65.20	50.83	18.55	2.62	25.23
Book Value [ExclRevalReserve]/Share (Rs.)	177.46	129.53	89.86	80.72	84.30
Book Value [InclRevalReserve]/Share (Rs.)	177.46	129.53	89.86	80.72	84.30
Revenue from Operations/Share (Rs.)	415.09	277.87	201.08	158.96	150.51
PBDIT/Share (Rs.)	91.11	73.94	30.55	20.13	35.54
PBIT/Share (Rs.)	79.72	63.21	22.00	13.24	29.65
PBT/Share (Rs.)	74.24	52.57	12.85	-7.32	27.08
Net Profit/Share (Rs.)	53.81	40.11	10.01	-4.26	19.34
NP After MI And SOA / Share (Rs.)	53.96	40.23	10.09	-4.24	19.36
Profitability Ratios
PBDIT Margin (%)	21.94	26.60	15.19	12.66	23.61
PBIT Margin (%)	19.20	22.74	10.94	8.33	19.70
PBT Margin (%)	17.88	18.92	6.38	-4.60	17.98
Net Profit Margin (%)	12.96	14.43	4.97	-2.68	12.85
NP After MI And SOA Margin (%)	13.00	14.48	5.01	-2.66	12.85
Return on Networth/Equity (%)	30.56	31.27	11.27	-5.27	23.04
Return on Capital Employed (%)	34.34	34.96	16.67	11.60	27.81
Return on Assets (%)	12.20	12.35	4.03	-1.97	9.59
Total Debt/Equity (X)	0.75	0.97	1.30	1.10	0.72
Asset Turnover Ratio (%)	1.08	0.97	0.87	0.76	0.82
Liquidity Ratios
Current Ratio (X)	1.35	1.33	1.20	1.12	1.20
Quick Ratio (X)	0.76	0.77	0.64	0.59	0.67
Inventory Turnover Ratio (X)	1.38	1.64	1.78	1.48	1.75
Dividend Payout Ratio (NP) (%)	8.33	7.45	14.86	-23.57	10.42
Dividend Payout Ratio (CP) (%)	6.87	5.88	8.05	37.79	7.98
Earnings Retention Ratio (%)	91.67	92.55	85.14	123.57	89.58
Cash Earnings Retention Ratio (%)	93.13	94.12	91.95	62.21	92.02
Coverage Ratios
Interest Coverage Ratios (%)	16.64	6.95	3.34	2.11	16.00
Interest Coverage Ratios (Post Tax) (%)	16.64	6.95	3.34	2.11	16.00
Valuation Ratios
Enterprise Value (Cr.)	39,050.10	18,372.29	7,435.54	5,973.37	7,283.13
EV/Net Operating Revenue (X)	3.22	2.27	1.27	1.29	1.66
EV/EBITDA (X)	14.68	8.52	8.36	10.19	7.04
MarketCap/Net Operating Revenue (X)	2.94	1.84	0.73	0.75	1.30
Retention Ratios (%)	91.66	92.54	85.13	123.57	89.57
Price/BV (X)	6.91	3.97	1.63	1.48	2.33
Price/Net Operating Revenue	2.94	1.84	0.73	0.75	1.30
Earnings Yield	0.04	0.08	0.07	-0.04	0.10